Insider Trading Alert - HELE, CSII And GOOD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 5, 2015, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $1,572,413.89.

Highlighted Stocks Traded by Insiders:

Helen of Troy (HELE) - FREE Research Report

Meeker Timothy F, who is Director at Helen of Troy, sold 3,000 shares at $87.00 on May 5, 2015. Following this transaction, the Director owned 8,278 shares meaning that the stake was reduced by 26.6% with the 3,000-share transaction.

The shares most recently traded at $86.35, down $0.65, or 0.75% since the insider transaction. Historical insider transactions for Helen of Troy go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Helen of Troy has been 165,900 shares per day over the past 30 days. Helen of Troy has a market cap of $2.5 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 35.03% year-to-date as of the close of trading on Tuesday.

Helen of Troy Limited, together with its subsidiaries, designs, develops, imports, markets, and distributes a portfolio of consumer products in the United States, Canada, Europe, Latin America, and internationally. The company has a P/E ratio of 19.4. Currently, there is 1 analyst who rates Helen of Troy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HELE - FREE

TheStreet Quant Ratings rates Helen of Troy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Helen of Troy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cardiovascular Systems (CSII) - FREE Research Report

Blackey Brent G, who is Director at Cardiovascular Systems, bought 2,500 shares at $29.38 on May 5, 2015. Following this transaction, the Director owned 57,145 shares meaning that the stake was boosted by 4.57% with the 2,500-share transaction.

The shares most recently traded at $32.61, up $3.23, or 9.9% since the insider transaction. Historical insider transactions for Cardiovascular Systems go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 29,338
  • 24-Week # shares bought: 10,250
  • 24-Week # shares sold: 56,375

The average volume for Cardiovascular Systems has been 261,200 shares per day over the past 30 days. Cardiovascular Systems has a market cap of $954.6 million and is part of the health care sector and health services industry. Shares are up 0.4% year-to-date as of the close of trading on Tuesday.

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. Currently, there are 7 analysts who rate Cardiovascular Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSII - FREE

TheStreet Quant Ratings rates Cardiovascular Systems as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Cardiovascular Systems Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Gladstone Commercial (GOOD) - FREE Research Report

Cutlip Robert G, who is President at Gladstone Commercial, bought 200 shares at $17.90 on May 5, 2015. Following this transaction, the President owned 16,000 shares meaning that the stake was boosted by 1.27% with the 200-share transaction.

Historical insider transactions for Gladstone Commercial go as follows:

  • 4-Week # shares bought: 500
  • 12-Week # shares bought: 1,550
  • 24-Week # shares bought: 2,750

The average volume for Gladstone Commercial has been 99,500 shares per day over the past 30 days. Gladstone Commercial has a market cap of $363.8 million and is part of the financial sector and real estate industry. Shares are up 3.9% year-to-date as of the close of trading on Tuesday.

Gladstone Commercial Corporation operates as a real estate investment trust (REIT) in the United States. It engages in investing in and owning net leased industrial and commercial real properties, and making long-term industrial and commercial mortgage loans. The stock currently has a dividend yield of 8.41%. Currently, there is 1 analyst who rates Gladstone Commercial a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GOOD - FREE

TheStreet Quant Ratings rates Gladstone Commercial as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full Gladstone Commercial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit